PHIA Koninklijke Philips N.V.

Philips teams with University of Kentucky's UK HealthCare to power state’s only eICU Clinical Command Center

Philips teams with University of Kentucky's UK HealthCare to power state’s only eICU Clinical Command Center

April 15, 2020

  • Academic medical center leverages Philips tele-ICU technology to enhance clinician experience and help improve outcomes for ICU patients in Kentucky
  • Application of virtual monitoring will help aid University of Kentucky (UK) Healthcare’s teams in care provision for COVID-19 patients

Amsterdam, the Netherlands and Lexington, KY, U.S. – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and , today announced a collaboration to create Kentucky’s only operating clinical command center for tele-critical care and operational optimization. Leveraging , the academic medical center is implementing a centralized virtual care model to help providers detect risk of patient deterioration so they can intervene earlier and help improve care outcomes for the organization’s sickest patients.

Philips’ eICU Program is built around , which uses advanced analytics and AI to synthesize patient data and deliver actionable insights to support proactive care. Using this comprehensive system, University of Kentucky (UK) HealthCare will provide 24/7 remote monitoring and access to specialists for patients in the neurological, trauma, surgery, post-anesthesia care, medical intensive care, emergency department and cardiovascular patient care venues. The institution also aims to improve bed utilization and patient flow across its 160 ICU beds at two hospitals.

Since COVID-19 is predominantly a respiratory illness, patients with more severe cases may require ICU care. eCareManager acuity based scoring tools monitor a patient’s condition to detect subtle deteriorations prior to becoming adverse events. Predictive AI-enabled algorithms such as , designed to focus on a patients cardiovascular and Respiratory systems, provide clinicians in the telehealth center with predictive insights into those patients with the highest probability of requiring an intervention in the next 60 minutes. As bed availability and critical decisions on patient throughput are required, eCareManager integrates as part of its Clinical Performance Applications Suite the , a predictive algorithm that provides clinicians objective scoring on a patients risk of death or readmission within 48 hours of a planned discharge.

“In these most challenging times, healthcare organizations need digital technology to enhance the patient experience, improve health outcomes, lower the cost of care, and enhance the work-life of care providers now more than ever before,” said , Chief Business Leader Connected Care, member of the Executive Committee at Royal Philips. “Partnering with UK HealthCare to address these concerns for the sickest patients demonstrates Philips’ commitment to deliver unique approaches to help meet the demand of healthcare’s greatest challenges.”

“This partnership is vital to our foundational vision of high value care.  Leveraging technology and highly developed clinical algorithms will aid our progressive high-performance health system,” said Dr. Colleen Swartz, Vice President for Hospital Operations at UK HealthCare. “Especially during this time of increased need for very specific isolation and care models in managing COVID-19 patients, the application of virtual monitoring will aid our teams in care provision. Philips is an essential partner in our efforts to progress care across the state.”

First of its kind outcomes-based partnership

As the shift to value-based care and reimbursement is increasingly dependent upon measurable outcomes, Philips and UK HealthCare plan to measure Key Performance Indicator metrics and will work together to identify improvement areas and generate mutual value. The partnership between UK HealthCare and Philips is a pioneering model in ICU telehealth, focused on addressing the quadruple aim by measuring outcomes across both clinical and operational value. The Philips eICU Program is uniquely positioned to partner with customers on innovative outcomes-based models in acute care. With the goal of improving patient care, clinical efficiencies, and ICU quality best practices through telehealth, eICU Program outcomes are demonstrated in peer reviewed publications.

As health systems seek to improve health outcomes, eICU programs enable a co-located team of intensivists and critical care nurses to remotely monitor patients in the ICU regardless of patient location, helping to optimize care costs and enhance clinician and patient satisfaction. Intensivists and nurses based in a telehealth eICU hub are supported by high-definition cameras and communications technology, predictive analytics, data visualization and advanced reporting capabilities to support their frontline colleagues.

Dashboards bring together data from the EMR and patient monitors on the ICU floor, where advanced algorithms alert to signs of deterioration helping the care team to proactively intervene at an earlier stage. eICU programs have been the subject of peer-reviewed literature since 2002, with outcomes data presenting clinical benefits in mortality reduction and operational systems benefits through increased throughput of ICU patients by reducing ICU patient length of stay [1].

Philips is the global leader in centralized tele-critical care. More than 20% of US adult ICU beds and 1 in 8 adult ICU patients are monitored by a 24/7 continuous demand model powered by the eICU Program, which combines A/V technology, predictive analytics, data visualization and advanced reporting capabilities [2, 3]. The core of this program is Philips eCareManager software, which delivers need-to-know information to caregivers, empowering them to care for the patients in a more proactive manner.

platforms are available around the globe with clinical informatics applications supporting bedside, unit and virtual care delivery models. For more information on how Philips is addressing the Coronavirus globally, please visit the .

[1] Lilly CM, et al. A Multi-Center Study of ICU Telemedicine Reengineering of Adult Critical Care. CHEST. 2014 Mar 1; 145(3): 500-7.

[2] Representative of the total Philips eICU licensed beds as a percentage coverage relative to total US adult ICU beds

[3] Derived from SCCM Adult ICU admission statistic and compared to eCareManager eRI annual monitored patients

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail:  

Twitter:

Silvie Casanova

Philips North America

Tel:

E-mail:

Kristi Willett

UK HealthCare PR

Tel.: 859-806-0445

Email:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

About UK HealthCare

is the hospitals and clinics of the University of Kentucky. But it is so much more. It is 9,000 people – physicians, nurses, pharmacists and other healthcare professionals – all dedicated to providing the most advanced, most effective care available, not just in Kentucky but anywhere. UK HealthCare is the power of advanced medicine.



Attachments

EN
15/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch